Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Medicine name : Sevabertinib
Generic name : Hyrnuo
Manufactured By : Bayer
Indications : HER2 TKD-Mutated Non-Squamous NSCLC
Medicine Description : A targeted oral therapy for HER2 tyrosine kinase domain (TKD)-mutated non-squamous non-small cell lung cancer (NSCLC), Sevabertinib (Hyrnuo) is a selective HER2 tyrosine kinase inhibitor designed to block abnormal HER2 signaling that drives tumor growth. It is used in patients whose disease has progressed after prior systemic therapies. Taken orally, it provides a precision-based treatment option aimed at improving disease control. Common side effects include diarrhea, nausea, fatigue, rash, and elevated liver enzymes. Regular monitoring is recommended to manage treatment-related adverse effects and ensure patient safety.